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Oxidativestressisthoughttoplayaroleinthepathogenesisofage-relatedmaculardegeneration(AMD).Wedeterminedtheextent
of oxidative DNA damage and the kinetics of its removal as well as the genotypes of the Ser326Cys polymorphism of the hOGG1
gene in lymphocytes of 30 wet AMDpatients and 30 controls. Oxidative DNA damage induced by hydrogen peroxide and its repair
were evaluated by the comet assay and DNA repair enzymes. We observed a higher extent of endogenous oxidative DNA damage
and a lower eﬃcacy of its repair in AMD patients as compared with the controls. We did not ﬁnd any correlation between the
extent of DNA damage and eﬃcacy of DNA repair with genotypes of the Ser326Cys polymorphism. The results obtained suggest
that oxidative DNA damage and ineﬃcient DNA repair can be associated with AMD and the variability of the hOOG1 gene may
not contribute to this association.
Copyright © 2009 Katarzyna Wozniak et al. This is an open access article distributed under the Creative Commons Attribution
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1.Introduction
Age-related macular degeneration (AMD) is a leading cause
of visual impairment and blindness in Western countries
among people aged 50 years and older [1]. The prevalence
of AMD in various European countries (Norway, Estonia,
United Kingdom, France, Italy, Greece, and Spain) was
3.32% with the of geographic atrophic AMD of 1.2%,
neovascularAMD2.3%andbilateralAMD1.4%[2].AMDis
also a signiﬁcant health problem in the United States, with a
currentestimateofabout1.75millionpersonswithadvanced
AMD in the general population and about 7.3 million people
with early stages of AMD deﬁned by large retinal drusen.
It has been projected that by the year 2020, approximately
about 2.95 million people will have advanced AMD and an
additional 6.4 million white individuals will have the early
stages of AMD in at least one eye [3]. AMD prevalence
has been rising across the globe. As the average life span of
humans continues to increase, especially in the developed
countries, the incidence of AMDis expected to nearly double
within the next 25 years.
The aetiology of AMD remains elusive because it is a
multifactorial disease in which both genetic and environ-
mental factors have been implicated. To date, age, smoking,
exposure to light, and diet have been successfully identiﬁed
[4, 5]. Various studies have indicated a signiﬁcant genetic
contribution to AMD, including those reported a higher
occurrence of AMD among monozygotic twins and ﬁrst-
degree relatives than spouses and unrelated individuals [6].
AMD was also associated with several DNA single nucleotide
polymorphisms (SNPs) [7–9].
Oxidative stress has been implicated in the pathogenesis
of AMD. The retinal pigment epithelium (RPE) cells func-
tion in an environment that is rich in endogenous reactive
oxygen species (ROS). The activity of RPE cells, the high
local oxygen concentration, and the chronic exposure to
light contribute to the production of ROS [10–13]. Although
multiple physiologic mechanisms protect the RPE from
the toxic eﬀects of light and oxidative damage, mounting
evidence suggests that chronic exposure to oxidative stress
over the long term may damage the RPE and predispose it
to the development of AMD. Supporting this theory is the2 Journal of Biomedicine and Biotechnology
observation that large drusen, which are deposited under
the RPE in patients with macular degeneration, consist of
insoluble aggregates of oxidized lipids and proteins derived
from the photochemical reactions of visual transduction
[14, 15].
In the present paper we checked the correlation between
the level of DNA damage measured with the alkaline comet
assay and the kinetics of removal of DNA damage induced
by hydrogen peroxide in peripheral blood lymphocytes of
patients with wet form of AMD and individuals without
visual disturbances. Most oxidative damage associated with
AMD will occur within postmitotic cells of the retina and
will be environmental in origin. We chose peripheral blood
lymphocytes as they would be aﬀected by the environmental
condition causing oxidative DNA damage in the retina.
Moreover, they could provide evidence on inherited defect in
DNA damage/repair, which would be enhanced by oxidative
stress. Furthermore, metabolic disturbances associated with
AMD may aﬀect whole organism [1]. We also correlated
the metrics of DNA damage and repair with the genotype
of the hOGG1 gene polymorphism: a C → G transversion
at 1245 position producing a Ser → Cys substitution at
the codon 326 (the Ser326Cys polymorphism). We chose
the hOGG1 gene due to its central role in the repair of
oxidatively damaged DNA. To evaluate the extent of DNA
damage, the eﬃcacy of DNA repair and the sensitivity to
exogenous mutagensin AMDpatients we determined (1)the
level of DNA damage measured by alkaline comet assay and
oxidative DNA damage and (2) the capacity to remove DNA
damage induced by hydrogen peroxide in the peripheral
bloodlymphocytesofAMDpatientsandhealthyindividuals.
DNA damage and repair were evaluated by alkaline single
cell gel electrophoresis (comet assay). Hydrogen peroxide is a
standard agent to induce oxidative DNA damage. In order to
assess the role of oxidative DNA damage in AMD patients,
we employed two DNA repair enzymes: endonuclease III
(Nth) and formamidopyrimidine-DNA glycosylase (Fpg),
preferentially recognizing oxidized DNA bases. Nth converts
oxidized pyrimidines into strand breaks, which can be
detected by the comet assay [16]. Fpg is a glycosylase
initiating base excision repair in E. coli. It recognizes
and removes 7,8-dihydro-8-oxoguanine (8-oxoguanine), the
imidazole ring-opened purines, 2,6-diamino-4-hydroxy-
5-formamidopyrimidine (Fapy-Gua), and 4,6-diamino-5-
formamido-pyrimidine (Fapy-Ade) as well as small amounts
of 7,8-dihydro-8-oxoadenine (8-oxoadenine) [17]. The
removing of speciﬁc modiﬁed bases from DNA by this
enzyme leads to apurinic or apirymidinic sites, which are
subsequently cleaved by its AP-lyase activity, giving a gap in
the DNA strand, which can be detected by the comet assay
[18].
2.MaterialsandMethods
2.1. Patients. Blood samples were obtained from patients
with wet form of AMD (n = 30) and healthy sex- and
age-matched individuals (n = 30). Medical history was
obtained from all subjects. The patients underwent oph-
thalmic examination including best-corrected visual acuity,
intraocular pressure, slit-lamp examination, and fundus
examination using noncontact and contact fundus lenses
with a slit lamp. Diagnosis of wet form AMD was con-
ﬁrmed by optical coherence tomography (OCT), ﬂuorescein
angiography (FA), and in some cases indocyanin green
angiography (ICG). OCT evaluated retinal thickness, the
presence of subretinal ﬂuid and intraretinal oedema; angiog-
raphy assessed the anatomical status of the retinal vessels,
the presence of choroidal neovascularisaton (CNV) and
leakage.
The OCT examinations were performed with Stratus
OCT model 3000, software version 4.0. The FA and ICG
examinations were completed with a Topcon TRC-50I IX
fundus camera with the digital Image Net image system (ver.
2.14; Topcon Co., Tokyo, Japan).
The Local Ethic Committee approved the study and
each patient gave a written consent. Neither patients nor
controls reported cancer, diabetes, or other disease known or
suspected to aﬀect DNA repair.
2.2. Cell Preparation. Blood samples were immediately
transported to the laboratory on ice. Peripheral blood
lymphocytes (PBL) were isolated by centrifugation in a
densitygradientofhistopaque-1077(15minutes,280g,4◦C)
and suspended in RPMI 1640 medium at 1–3 × 105 cells per
mL.
2.3. Comet Assay. The comet assay was performed at pH
>13 essentially according to the procedure of Singh et al.
[19] with modiﬁcations [16, 18] as described previously
[20]. A freshly prepared suspension of the cells in 0.75%
LMP agarose dissolved in PBS was spread onto microscope
slides precoated with 0.5% NMP agarose. The cells were
then lysed for 1 hour at 4◦Ci nab u ﬀer consisting of 2.5M
NaCl, 100mM EDTA, 1% Triton X-100, 10mM Tris, pH 10.
After the lysis, the slides were placed in an electrophoresis
unit, DNA was allowed to unwind for 20 minutes in the
electrophoresis solution consisting of 300mM NaOH and
1mM EDTA, pH >13. Electrophoresis was conducted at
ambient temperature of 4◦C (the temperature of the running
buﬀer did not exceed 12◦C) for 20minutes at an electric
ﬁeld strength of 0.73V/cm (28mA). The slides were then
washed in water, drained and stained with 2μg/mL DAPI,
and covered with cover slips. To prevent additional DNA
damage, all the steps described above were conducted under
dimmed light or in the dark.
T h ec o m e t sw e r eo b s e r v e da t2 0 0× magniﬁcation in
an Eclipse ﬂuorescence microscope (Nikon, Tokyo, Japan)
attached to COHU 4910 video camera (Cohu, San Diego,
CA, USA) equipped with a UV-1 ﬁlter block (an excitation
ﬁlter of 359nm and a barrier ﬁlter of 461nm) and connected
to a personal computer-based image analysis system Lucia-
Comet v. 4.51 (Laboratory Imaging, Praha, Czech Republic).
One hundred images were randomly selected from each
sample and the percentage of DNA in the tail of comets was
measured.Allthevaluesinthisstudywereexpressedasmean
± S.E.M.Journal of Biomedicine and Biotechnology 3
2.4.DNADamageandRepair. Hydrogenperoxidewasadded
to the suspension of the cells to give a ﬁnal concentration of
10μM.Lymphocyteswereincubatedwithhydrogenperoxide
for 10 minutes at 4◦C. The cells after treatment were washed
and resuspended in RPMI 1640 medium. A freshly prepared
suspension of the cells in LMP agarose dissolved in PBS was
spread onto microscope slides. The slides were processed as
described in the Section 2.3.
To examine DNA repair, the cells, after treatment with
hydrogen peroxide, were washed and resuspended in a fresh,
RPMI 1640 medium preheated to 37◦C. Aliquots of the cell
suspension were taken immediately “time zero” and at 120
minutes later. Placing the samples in an ice bath stopped
DNA repair. The slides were processed as described in the
Section 2.3.
Weconsideredarelativediﬀerencebetweentheextentsof
D N Ad a m a g ea t“ t i m ez e r o ”a n d1 2 0m i n u t e sa sam e a s u r eo f
the eﬃcacy of DNA repair.
2.5. DNA Repair Enzymes Treatment. A freshly prepared
suspension of the cells in LMP agarose dissolved in PBS
was spread onto microscope slides. The slides after cell lysis
were washed three times (5 minutes, 4◦C) in an enzyme
buﬀer containing 40mM HEPES-KOH, 0.1M KCl, 0.5mM
EDTA, 0.2mg/mL bovine serum albumin, pH 8.0. The slides
were then drained and incubated for 30 minutes at 37◦C
with 0.03μg of Nth or Fpg in this buﬀer [16, 18]. The
control received only the buﬀer. The slides were processed
as described in the Section 2.3. Each value of oxidative DNA
modiﬁcation recognized by these enzymes derives a mean
diﬀerence between Fpg/Nth-treated and nontreated control
from30patientswithAMDand30healthycontrols.Tocheck
the ability of the enzymes to recognize oxidized DNA bases
inourexperimentalconditions,thecellswereincubatedwith
hydrogen peroxide, lysed, and posttreated with Fpg or Nth.
2.6. Genotype Determination. Genomic DNA was prepared
from peripheral blood of AMD patients and healthy individ-
uals by using of commercial Blood Mini Kit (AKOR Labo-
ratories, Gdansk, Poland). The genotypes of the Ser326Cys
polymorphismofthehOOG1geneweredeterminedwiththe
following primers: sense 5 -GTTTTCACTAATGAGCTTGC-
3 , antisense 5 -AGTGGTATAATCATGTGGGT-3 .T h e
200bp PCR product was digested overnight with 5U of the
restriction enzyme SatI (Fermentas, Vilnius, Lithuania). The
Cys allele was digested into 100bp fragments, whereas the
Ser variant remained intact. The PCR products were run on
2.5% agarose gel.
2.7.DataAnalysis. Thevaluesofthecometassayinthisstudy
were expressed as mean ± S.E.M. from two experiments,
that is, data from two experiments, 100 measurements each,
were pooled and the statistical parameters were calculated.
If no signiﬁcant diﬀerences between variations were found,
as assessed by Snedecor-Fisher test, the diﬀerences between
means were evaluated by applying the Student’s t test. Oth-
erwise, the Cochran-Cox test was used. Relative diﬀerence
between extents of DNA damage in time zero and 120
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Figure 1: Endogenous DNA damage (DNA strand breaks and
alkali-labile sites), measured as the mean comet percentage tail
DNA in the alkaline comet assay in human peripheral blood
lymphocytes of healthy controls (white bar) and AMD patients
(grey bar). Thirty individuals were analysed in either group. The
number of cells scored for each individual was 100. The results
displayed are the mean of three independent experiments ± S.E.M.
∗∗∗P<. 001.
minutes expressed in percentage was used as a measure of
the eﬃcacy of DNA repair after treatment with hydrogen
peroxide. Distribution of genotypes and alleles between
groups was analysed using the χ2-test. Relationship between
genotype and cancer was assessed by the logistic regression.
The data were analysed using Statistica package (StatSoft,
Tulsa, OK, USA).
3. Results
3.1. DNA Damage. The mean extent of endogenous DNA
damage measured as the percentage of DNA in comet tail
of lymphocytes of AMD patients and controls is displayed
in Figure 1. We observed a higher level of endogenous DNA
damage in AMD patients than in the controls (P<. 001).
3.2. Endogenous Oxidative DNA Damage. Figure 2 presents
the mean DNA damage measured as percentage tail DNA
of lymphocytes from AMD patients and healthy individ-
uals, lysed and posttreated with Nth (Figure 2(a))o rF p g
(Figure 2(b)). Subtracting the values for an enzyme-speciﬁc
buﬀer only treatment normalized these results. Therefore,
the results indicate solely the DNA base-modiﬁcation, which
are not alkali-labile. There were signiﬁcant diﬀerences (P<
.01) between the mean extent of oxidative DNA damage
recognized by Nth between AMD patients and controls
(Figure 2(a)). There were no signiﬁcant diﬀerences (P>
.05) between the mean extent of oxidative DNA damage
recognized by Fpg between AMD patients and controls
(Figure 2(b)).
Because high level of oxidative DNA damage may be
associatedwithanimpairedDNArepair,individualswiththe
extent of oxidative DNA damage higher than the mean for
respective group were selected for further genotype analysis.4 Journal of Biomedicine and Biotechnology
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Figure 2: Oxidative DNA damage in peripheral blood lymphocytes
of 30 AMD patients (grey bars) and 30 healthy controls (white bars)
recognized by Nth (a) or Fpg (b) at 1μg/mL in the alkaline comet
assay. Each bar is a mean diﬀerence between Fpg or Nth treated
cells and enzyme-nontreated controls. DNA damage was measured
as the percentage of DNA in the tail in the alkaline comet assay.
The number of cells scored for each individual was 100. The results
displayed are the mean of three independent experiments ± S.E.M.
∗∗P<. 01.
3.3. DNA Repair. The mean percentage tail DNA of lym-
phocytes from AMD patients and controls exposed for 10
minutes to 10μM hydrogen peroxide immediately after the
exposure as well as 120 minutes thereafter is presented in
Table 1 along with the eﬃcacy of DNA repair. The “minus”
sign indicates that the extent of DNA damage at 120 minutes
was greater than at the zero time. The eﬃcacy of DNA
repair in AMD patients was signiﬁcantly (P<. 001) lower
than that observed in the controls. Moreover, the extent
of initial DNA damage after hydrogen peroxide treatment
was signiﬁcantly higher in AMD group than in the control
(P<. 01). We assumed that ineﬃcient DNA repair occurred
whenwedidnotobservesigniﬁcantdecreaseinDNAdamage
after 120 minutes of repair incubation. We did not observe
any diﬀerence in the mean eﬃcacy of DNA repair between
AMD patients (21 subjects with ineﬃcient DNA repair) and
control group (17 subjects with ineﬃcient DNA repair).
However, the data show that all control samples showed
decreaseinDNAdamageafter120minutes.43%oftheAMD
patients(13persons)showafurtherincreaseinDNAdamage
at 120 minutes. These results suggest that the eﬃcacy of the
repair of oxidative DNA damage in AMD patients was lower
than in the controls. We observed considerable diﬀerences
in the eﬃcacy of DNA repair between individuals enrolled
in the study, especially in AMD patients. We speculate
that it could be linked with diﬀerent activity of allelic
variants of genes involved in the repair of oxidative DNA
lesions.Toverifythishypothesis,weselectedonlyindividuals
with ineﬃcient DNA repair (Table 1) for further genotype
analysis.
3.4. Genotype Analysis. There were no signiﬁcant diﬀerences
between the distributions of genotypes of the Ser326Cys
polymorphism of the hOGG1 gene and the frequency of the
Ser and Cys alleles for AMD patients and controls with high
level of endogenous oxidative DNA damage (Table 2). There
also were no signiﬁcant diﬀerences between the distributions
of the genotypes and frequencies of the alleles of the
Ser326Cys polymorphism for AMD patients and controls
withimpairedDNArepairafterhydrogenperoxidetreatment
(Table 3).
4. Discussion
Oxidative damage to RPE cells and photoreceptors has been
implicated in the pathogenesis of AMD. This kind of cellular
stress induces various types of DNA damage, like base
modiﬁcations, DNA breaks, and alkali-labile sites. They are
mainly removed by base excision repair (BER) pathway. BER
removes modiﬁed base by speciﬁc glycosylases, which can
be assisted by endonucleases. The next steps are abasic site
priming, gap ﬁlling, and ligation. 8-Hydroxydeoxyguanosine
(8-OH-Gua) glycosylase 1 (hOGG1) is the primary enzyme
for the repair of 8-OH-Gua in human cells [21]. The
presence of 8-OH-Gua residues in DNA leads to a GC→TA
transversion,unlessitisrepairedbeforeDNAreplication.For
this reason, the presence of 8-OH-Gua in DNA may lead to
mutagenesis and the level of 8-OH-Gua is commonly used as
a biomarker of oxidative DNA damage [22].
A growing body of evidence suggests that mitochondrial
dysfunction may be associated with AMD and proposes a
speciﬁc pathophysiological mechanisms involving mtDNA
oxidative damage, altered mitochondrial translation, import
of nuclear-encoded proteins and ATP synthase activity as an
explanation of this association [23–25]. Unfortunately, data
on the involvement of DNA repair in AMD pathogenesis are
scare. There are a few reports focusing on the mitochondrial
DNA. These reports suggest increased mitochondrial DNA
damage and downregulation of mitochondrial DNA repair
in RPE cells and choroid. An increased level of 8-OHdG
and downregulation of base excision glycosylases in aged
rodent RPE and choroid as compared with young controls
was also reported [23]. The recent data indicate also that
the altered function of the putative mitochondrial pro-
tein LOC387715/ARMS2 by a 69A>S substitution stronglyJournal of Biomedicine and Biotechnology 5
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Table 2: The allele and genotype frequencies and odds ratio (OR) of the Ser326Cys polymorphism of the hOGG1 gene in AMD patients and
controls with the extent of endogenous oxidative DNA damage higher than the mean for respective group.
Genotype or allele Controls (n = 20) AMD patients (n = 14) OR (95% PU)
Number Frequency Number Frequency
Ser/Ser 11 0.55 10 0.71 2.05 (0.48–8.78)
Ser/Cys 9 0.45 4 0.29 0.49 (0.11–2.09)
Cys/Cys 0 — 0 — —
Ser 31 0.77 24 0.86 1.74 (0.48–6.35)
Cys 9 0.23 4 0.14 0.57 (0.16–2.09)
Table 3: The allele and genotype frequencies and odds ratio (OR) of the Ser326Cys polymorphism of the hOGG1 gene in AMD patients
with ineﬃcient repair of DNA lesions induced by hydrogen peroxide. Ineﬃcient DNA repair occured when we did not observe a signiﬁcant
decrease in the extent of DNA damage after 120 minutes of repair incubation.
Genotype or allele Controls (n = 17) AMD patients (n = 21) OR (95% PU)
Number Frequency Number Frequency
Ser/Ser 9 0.53 11 0.52 0.98 (0.27–3.52)
Ser/Cys 8 0.47 10 0.48 1.02 (0.28–3.68)
Cys/Cys 0 — 0 — —
Ser 26 0.76 32 0.76 0.98 (0.34–2.85)
Cys 8 0.24 10 0.24 1.02 (0.35–2.94)
enhances the susceptibility to aging-associated degeneration
of macular photoreceptors [26].
The number of patients we analyzed may not seem
to be impressive as compared with epidemiological studies
assessing a risk linked with particular genotype/phenotype.
T h ep r i m a r yg o a lo fo u rs t u d yw a st os e a r c hf o rac o r -
relation between genotype and phenotype, although we
calculated the odds ratio, because it is a standard procedure
in polymorphism study. Such studies with comet assay
are typically performed on a population of several dozen
individuals and very exceptionally this number exceeds one
hundred.
Although oxidative stress is usually linked with the
dry AMD and so are the disturbances in the DNA repair
machinery,ourresultssuggestextendingthispointofviewto
wetAMD.Theymayalsosuggestacloserassociationbetween
the two forms of the disease.
Our study was performed on peripheral blood lympho-
cytes. They should have been performed on the retina cells,
but these cannot be obtained from live AMD patients as
easily as the lymphocytes. Lymphocytes are easily accessible
and their genetic constitution with the regards of DNA
repair processes reﬂects that of the retina cells. There is no
doubt that AMD is not only an ocular disease. However, we
found a decreased eﬃcacy of DNA repair in peripheral blood
lymphocytes of AMD patients, but we do not have any solid
evidence that this eﬀect was a consequence of AMD. This is
rather an open question. We hypothesize that AMD may be a
result of a decreased capability of every cell of an organism
to repair DNA damage and increased exposure of ocular
cells to etiological agents, like UV radiation, inducing DNA
damage in these cells. On the other hand, we cannot exclude
the possibility that the observed decrease in the eﬃcacy of
DNA repair may be a consequence of general metabolic
disturbance associated with AMD. We think that the results
we obtained suggest that there may be an interplay between
disturbances in the general state of an organism, manifested
by decreased eﬃcacy of DNA repair and local (ocular)
changes evoked by genetic and environmental factors.
We used the comet assay to study DNA damage and
repair. This technique is a versatile and sensitive method for
measuring DNA damage such as single- and double-strand
breaks as well as alkali-labile sites in DNA. It is a valuable
tool in population monitoring, for example, in assessing the
role of oxidative stress in human disease and in monitoring
the eﬀects of dietary antioxidants. A simple modiﬁcation
allows the measurement of DNA repair. In combination
with the analysis of polymorphisms in relevant genes, comet
assay may provide important information on the interaction
between genetic variation and environmental factors in the
maintaining genome stability [27].
Although the increase in the tail DNA in AMD patients
as compared with the controls was statistically signiﬁcant it
should not be a priori considered as biologically or medically
relevant. However, because AMD may be considered as a
multifactorial disease, this increase may signiﬁcantly con-
tribute to the disease.
The eﬃcacy of DNA repair may be aﬀected by variation
inDNArepairgenes.Severaltypesofgeneticpolymorphisms
can be found within the human genome, such as repeat
polymorphisms, insertions, and deletions. However, most
DNA sequences variation in human populations is in the
form of SNPs [28]. SNPs can be deﬁned as persistent
substitutions of a single base with a frequency of more
than 1% in at least one population. Recently, it has been
demonstrated the potential role of SNPs in AMD and
other age-related diseases [29]. Three SNPs in the MnSOD,
MEHE, and Paraoxonase genes related to oxidative stressJournal of Biomedicine and Biotechnology 7
have previously been reported in association with AMD in
Japanese populations [30, 31].
It seems that the hOGG1 gene is a good candidate
to study DNA repair genes, which can be associated with
AMD. This gene is expressed in multiple alternatively spliced
isoforms and is highly polymorphic [32]. OGG1-type 1a of
hOGG1 gene is constitutively expressed in cancerous and
noncancerous human cells as nuclear form of protein [33].
T h ep r o t e i nl e v e lo fhOGG1 decreases in aged RPE and
choroids cells [23]. A C → G transversion at 1245 position
in the exon 7 of the hOGG1 gene results in an amino
acid substitution from serine to cysteine in the codon 326.
There are contradictory results of studies on the role of this
polymorphism in the catalytic activity of hOGG1 protein,
but it was shown that the Ser326 allele exhibited higher
enzymatic activity than the Cys326 variant in an in vitro
E. coli complementation assay [34]. Several studies have
suggested that Cys326 type allele may be associated with the
increased risk for esophageal [35], otolaryngeal [36], lung
[37], stomach [38], and prostate cancers [39].
In our studies we did not ﬁnd signiﬁcant diﬀerences
between the distributions of Ser326Cys polymorphism of
hOGG1 gene and the frequency of the Ser and Cys alleles for
AMD patients and controls with high level of endogenous
oxidative DNA damage and impaired DNA repair after
hydrogen peroxide treatment. This is not surprising due to a
limited number of patients enrolled in our study and a high
variability in the DNA repair rate between them. A lack of
association between the Ser326Cys polymorphism and AMD
was also demonstrated in other research [40]. However,
further studies are needed to conﬁrm the lack of association
between the Ser326Cys polymorphism and AMD.
Geneticvariabilityofthegenesinvolvedintheexpression
of the hOGG1 gene may also contribute to the eﬃcacy
of DNA repair. The Cockayne syndrome B (CSB)g e n e ,
also called ERCC6, collaborates with hOGG1 to carry out
preferentialDNArepairineukaryotes[41,42].Thisgenealso
plays a role in the maintenance of an eﬃcient expression of
the hOGG1 gene. It was shown that the G allele of the C-
6530CpolymorphismoftheERCC6 genecouldbeassociated
with a risk of AMD development and possibly interacted
with an SNP in the CFH gene (complement factor H gene)
to inﬂuence AMD susceptibility [7]. Recently, several studies
have also shown a strong association of CFH SNPs with
AMD [43–45]. It was revealed that ERCC6 C-6530G, which
is located in the regulatory region of the gene, upregulated
thetranscriptandproteinexpression.Thesedatasupportthe
hypothesis that DNA repair mechanisms may play a role in
AMD pathogenesis.
5. Conclusions
Our results suggest that endogenous oxidative DNA damage
and low eﬃcacy of DNA repair can be associated with the
occurrenceofAMDinwetform.HighlevelofoxidativeDNA
damage and impaired repair of such damage may not be
associated with the variants of the Ser326Cys polymorphism
of the hOGG1 gene.
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